1-4 of 4
Claudine Chollet
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prospective Evaluation of ABL Kinase Domain Mutational Analysis By Next-Generation-Sequencing in Newly Diagnosed CP CML Patients Undergoing First-Line Treatment with Nilotinib Alone or Nilotinib + Pegylated Interferon-α2a in a Prospective Phase III Trial

Hugues de Lavallade, MD PhD, Sophie Jackson, BSc, Aytug Kizilors, PhD, Gabriel Etienne, MD PhD, Francoise Huguet, MD, Agnes Guerci-Bresler, MD PhD, Delphine Rea, MD, Claudine Chollet, MSc, Stephane Morisset, BioStat, Fanny Robbesyn, BSc, Francois-Xavier Mahon, MD PhD, Stephanie Dulucq, PharmD, PhD, Franck E Nicolini, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 664.
https://doi.org/10.1182/blood-2019-125108
Published: 2019
Journal Articles

A Single Nucleotide Polymorphism in Pro-Apoptotique Protein BIM Affects Chronic Myeloid Leukaemia Evolution during Imatinib Treatment

Vanessa Augis, Francis Belloc, Kelly Airiau, Claudine Chollet, Francois-Xavier Mahon
Journal: Blood
Blood (2008) 112 (11): 4227.
https://doi.org/10.1182/blood.V112.11.4227.4227
Published: 2008
Journal Articles

Defensine Alpha1 as a New Marker of Imatinib Resistance in Chronic Myelogenous Leukemia

Gabriel Etienne, Maryse Dupouy, Claudine Chollet, Jean-Max Pasquet, Eric Lippert, Josy Reiffers, François- Xavier Mahon, Beatrice Turcq
Journal: Blood
Blood (2008) 112 (11): 3180.
https://doi.org/10.1182/blood.V112.11.3180.3180
Published: 2008
Journal Articles

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models

François-Xavier Mahon, Francis Belloc, Valérie Lagarde, Claudine Chollet, François Moreau-Gaudry, Josy Reiffers, John M. Goldman, Junia V. Melo
Journal: Blood
Blood (2003) 101 (6): 2368–2373.
https://doi.org/10.1182/blood.V101.6.2368
Published: 2003